Sysmex Corporation (HQ: Kobe, Japan; Chairman and CEO: Hisashi Ietsugu) announced today its launch of the CS-1600 automated blood coagulation analyzer, a new compact model in the hemostasis field.
Reflecting this environment, the global market for hemostasis has grown. In future, the rate of growth is expected to be particularly high in China and other emerging markets that are enjoying rapid economic expansion.
In 1995, Sysmex entered into a distribution agreement with Siemens Healthcare Diagnostics Inc., which has a leading share of the global market for hemostasis reagents. The two companies supply and distribute each other's instruments and reagents globally, maintaining the top global market share in the hemostasis field.
In 2006, Sysmex introduced the CS-2000i/2100i automated coagulation blood analyzer, the first in the world to employ a multi-wavelength transmitted light detection system. In 2011, we launched a high-end automated blood coagulation analyzer, the CS-5100. In 2014, we augmented functionality and ease of use in the CS-5100 and incorporated new analytical functions in a new desktop model, the CS-2400/2500, enhancing our lineup of hemostasis instruments and reagents and meeting customer demand by providing solutions including support services. In these ways, Sysmex has continued with the global introduction of the CS-Series.
The new CS-1600 is a compact model in the CS-Series, incorporating the technological capabilities and expertise Sysmex has accumulated in the hemostasis field. Carrying forward the core performance and functionality of the CS-5100, the model aimed principally at large-scale laboratories and our high-performance desktop model, the CS-2400/2500, the CS-1600 is more compact and easy to use. Representing the ongoing progress of the CS-Series, the CS-1600 targets laboratories which run a relatively small number of tests. We also anticipate rising demand for use as a backup instrument.
The new model incorporates SNCS® (Sysmex Network Communication Systems) functionality, allowing for online quality control and preventive maintenance, increasing the level of support services available in the hemostasis field.
Starting with a launch in Japan, Sysmex will progressively introduce this model in global markets, including China and other parts of Asia, as well as Russia.
Going forward, Sysmex aims to continue reducing the burden on patients and enhancing their quality of life, as well as instilling its customers with confidence. Sysmex and Siemens Healthcare Diagnostics will leverage their global networks to respond to broad-based customer needs in the hemostasis field, which are becoming increasingly diverse and sophisticated. As a result, we aim to contribute to diagnosis and health monitoring by offering highly reliable test results.
New Product Overview | |||
Name: |
Automated Blood Coagulation Analyzer CS-1600 |
||
Target market: |
All regions |
||
Launch: | Japan: January 28, 2015 (Outside Japan: to be launched successively in individual countries after receiving regulatory approval) | ||
Processing capacity: | Up to 120 tests/hour |
Test Parameters* | ||||
Coagulation: |
PT, APTT, Fbg, TTO, HpT, Coagulation Factors (extrinsic and intrinsic) |
|||
Chromogenic: | AT, PLG, α2PI, PC | |||
Turbidimetric immunoassay: | D-Dimer, FDP, PIC, FM, VWF:Ag | |||
* Target market: Japan |
Features | ||
|
Automated Blood Coagulation Analyzer CS-1600